🎯 check Momelotinib (CYT387) product page
Momelotinib (CYT387) is a potent JAK1/JAK2 inhibitor. It affects the JAK/STAT signaling pathway by binding to the kinase domain, effectively suppressing tumor cell proliferation, cytokine signaling, and cancer chemoresistance.